Insider · CIK 0001242825
Jeffrey M Leiden
chairofficerdirector
Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Nov 17, 2025, latest Dec 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $61M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRTX: VERTEX PHARMACEUTICALS INC / MA
VRTXOct 9, 2026 · close 510.08
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | VERTEX PHARMACEUTICALS INC / MA | $29M 63,781 shares | -73% | +26% from low-10% from high | |
| 38Weak | VERTEX PHARMACEUTICALS INC / MA | $32M 73,292 shares | -168% | +19% from low-15% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Common Stock10b5-1 | +63,781 | $86.52 | $5.5M | 87,807 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -4,469 | $440.40 | $2.0M | 83,338 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,320 | $441.26 | $582k | 82,018 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,469 | $443.21 | $1.1M | 79,549 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -4,352 | $444.36 | $1.9M | 75,197 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -7,899 | $445.56 | $3.5M | 67,298 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,152 | $447.05 | $515k | 66,146 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,320 | $448.78 | $1.0M | 63,826 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -5,880 | $449.84 | $2.6M | 57,946 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -5,809 | $451.20 | $2.6M | 52,137 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -15,681 | $452.20 | $7.1M | 36,456 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -10,360 | $453.34 | $4.7M | 26,096 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,070 | $455.22 | $942k | 24,026 | Dec 5, 2025 |
| Dec 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Common Stock10b5-1 | +1 | $91.05 | $91 | 24,027 | Dec 5, 2025 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -63,781 | $0.00 | $0 | 0 | Dec 5, 2025 |
| Dec 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1 | $0.00 | $0 | 0 | Dec 5, 2025 |
| Nov 13, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Common Stock10b5-1 | +19,688 | $91.05 | $1.8M | 43,714 | Nov 17, 2025 |
| Nov 13, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -18,528 | $440.22 | $8.2M | 25,186 | Nov 17, 2025 |
| Nov 13, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,160 | $441.05 | $512k | 24,026 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Common Stock10b5-1 | +13,835 | $91.05 | $1.3M | 37,861 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Common Stock10b5-1 | +39,769 | $86.52 | $3.4M | 77,630 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -32,234 | $440.30 | $14M | 45,396 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -21,330 | $441.35 | $9.4M | 24,066 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -40 | $442.00 | $18k | 24,026 | Nov 17, 2025 |
| Nov 13, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -19,688 | $0.00 | $0 | 13,836 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,835 | $0.00 | $0 | 1 | Nov 17, 2025 |
| Nov 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -39,769 | $0.00 | $0 | 63,781 | Nov 17, 2025 |
| Feb 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -6,066 | $463.46 | $2.8M | 24,026 | Feb 19, 2025 |
| Feb 12, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +7,209 | $0.00 | $0 | 32,617 | Feb 14, 2025 |
| Feb 13, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock | -2,525 | $450.83 | $1.1M | 30,092 | Feb 14, 2025 |
| Feb 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +15,414 | $0.00 | $0 | 25,408 | Feb 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.